A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

MB Faries, RK Gupta, X Ye, C Lee, R Yee… - Cancer …, 2007 - Taylor & Francis
Purpose: There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …
被引用次数：44 相关文章

A comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

MB Faries, RK Gupta, X Ye, C Lee… - Cancer …, 2007 - providence.elsevierpure.com
Purpose: There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …

A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

MB Faries, RK Gupta, X Ye, C Lee… - Cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …

[引用][C] Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

F MB - Cancer Invest, 2007 - cir.nii.ac.jp

A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.

MB Faries, RK Gupta, X Ye, C Lee, R Yee… - Cancer …, 2007 - europepmc.org
Purpose There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …

[引用][C] A comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients

MB FARIES, RK GUPTA, YE XING, C LEE… - Cancer …, 2007 - Informa Healthcare